In our blog post prepared with insights from Prof. Dr. Hasan Türkez, we cover:
-Beyond classic toxicology methods: leveraging multi-omics technologies and 3D cell models for more accurate and early-stage drug safety assessments.
-Under the leadership of Prof. Dr. Hasan Türkez: systematically tracking biological responses at the cellular level to create individualized safety profiles.
-Through Trustlife’s innovative laboratory infrastructure and AI-powered analysis: conducting long-term safety tests in critical areas such as neurotoxicity and genotoxicity.
-How these new approaches reduce risks in preclinical phases while improving cost and time efficiency, and advancing Turkey’s leadership in drug safety.
